作为早产婴儿的益生菌Bifidobacterium infantis:一个系统的审查和元分析
Vamsi K Batta1,2, Shripada C Rao3,4, Sanjay K Patole2,5
1Neonatal Intensive Care Unit, Perth Children's Hospital, Perth, WA, Australia.
Pediatric research
|July 17, 2023
概括
含有Bifidobacterium infantis的益生菌补充剂可能为早产婴儿提供更大的益处. 这次审查发现,与其他益生菌相比,B. infantis益生菌显著降低了结核性肠球炎的风险.
科学领域:
- 新生儿研究新生儿研究
- 微生物组科学 微生物组科学
- 益生菌研究 益生菌研究
背景情况:
- 双细菌婴儿利用母乳中的寡糖.
- 假设:B. infantis的益生菌为早产婴儿提供了增强的益处.
研究的目的:
- 评估B. infantis补充剂是否为早产婴儿提供了优势.
- 关于B. infantis在早产婴儿中的益生菌的第一个系统审查.
主要方法:
- 系统性审查和RCT的元分析.
- 在早产/低出生体重婴儿中,比较益生菌与安慰剂.
- 分析结果:死结肠炎 (NEC),晚期发作的败血症 (LOS),死亡率.
主要成果:
- 分析了67个RCT (14,606名婴儿).
- 益生菌降低了NEC,LOS和整体死亡率.
- B. infantis子组的NEC减少显著增加 (RR 0.38) 与非B. 婴儿 (RR 0.67) 的情况.
结论:
- 间接证据表明,B. infantis益生菌可能对早产婴儿更有益.
- 结果指导未来的研究和临床实践.
- 需要进一步的精心设计的RCT来确认.
相关概念视频
Anatomy of the Intestines
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Introduction to the Human Microbiota
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...


